- Home
- BRCB vs KROS Comparison
BRCB vs KROS Comparison
Compare BRCB & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRCB | KROS |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | 2800 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.8M | 206.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BRCB | KROS |
|---|---|---|
| Price | $8.16 | $10.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $24.83 | $21.86 |
| AVG Volume (30 Days) | ★ 399.9K | 313.0K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $243,864,000.00 |
| Revenue This Year | $30.74 | N/A |
| Revenue Next Year | $24.06 | $2,751.79 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.11 | $9.69 |
| 52 Week High | $30.40 | $22.55 |
Technical Indicators
Market Signals| Indicator | BRCB | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 43.32 |
| Support Level | $7.15 | $10.14 |
| Resistance Level | $8.79 | $11.55 |
| Average True Range (ATR) | 0.56 | 0.58 |
| MACD | 0.09 | -0.04 |
| Stochastic Oscillator | 59.15 | 9.02 |
Price Performance
Historical ComparisonAbout BRCB Black Rock Coffee Bar Inc.
Black Rock Coffee Bar Inc is an operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by its engaging baristas. The company offers wide variety of coffee from classic espresso-based drinks such as Lattes, Americanos, and Cappuccinos, as well as signature creations like the Caramel Blondie, Mexican Mocha, and Blackout. It offers a variety of savory and sweet items, including breakfast burritos, sausage cheddar sandwiches, banana bread, and glazed donut holes.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.